The decision between Curaderm and Mohs Surgery depends on your specific situation.
Patients who need to treat basal cell carcinoma and squamous cell carcinoma have two principal treatment options : surgery and topical non-surgical therapy. Mohs surgery stands as an effective surgical treatment, yet Curaderm BEC5 presents a plant-based topical solution.
The cure rate of Mohs surgery reaches 99% when treating specific types of BCC. The treatment process involves gradual tissue removal with microscopic examination of each layer until all cancerous cells disappear. The procedure delivers excellent results for facial lesions, together with cancers that have unclear boundaries.
The cancer-fighting compounds in Curaderm BEC5 derive from eggplant extract solasodine glycosides which specifically attack cancer cells without harming normal skin tissue. Patients need to apply the cream multiple times per day according to the prescribed duration, which ranges from 6 to 12 weeks based on the cancer severity.
So, which should you choose?
Mohs surgery becomes the better option in the following situations:
- The lesion appears on your face or exists in a sensitive location.
- The cancer has returned or shows signs of being aggressive.
- You need a quick treatment that takes place in an office setting.
Curaderm stands as a suitable option when:
- You seek an alternative to surgery.
- The cancer exists outside critical body regions.
- You prefer plant-based or topical therapies.
Medical professionals have validated both treatment options but they present different advantages and disadvantages. Most patients select their treatment based on their personal comfort level as well as their cosmetic preferences and treatment accessibility. Your dermatologist will evaluate your specific situation to determine the most suitable course of action.